HCA Healthcare Reports Second Quarter 2020 Results

Go back to HCA Healthcare Reports Second Quarter 2020 Results

HCA Holdings (HCA) PT Raised to $145 at Mizuho Securities

July 23, 2020 6:50 AM EDT

Mizuho Securities analyst Ann Hynes raised the price target on HCA Holdings (NYSE: HCA) to $145.00 (from $136.00) while maintaining a Buy rating.

The analyst commented, "We are raising our price target to $145 (from $136) following better-than-expected earnings. Inpatient revenue was the surprise, with revenue only... More

HCA Holdings (HCA) Tops Q2 EPS by $3.74, Revenues Beat

July 22, 2020 7:32 AM EDT

HCA Holdings (NYSE: HCA) reported Q2 EPS of $3.23, $3.74 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $11.07 billion versus the consensus estimate of $9.91 billion.

Key second quarter metrics (all percentage changes compare 2Q 2020 to 2Q 2019 unless otherwise noted):

Revenues totaled $11.068... More